The role of PI3K/AKT-related PIP5K1α and the discovery of its selective inhibitor for treatment of advanced prostate cancer J Semenas, A Hedblom, RR Miftakhova, M Sarwar, R Larsson, ... Proceedings of the National Academy of Sciences 111 (35), E3689-E3698, 2014 | 104 | 2014 |
Comparative cytotoxicity of kaolinite, halloysite, multiwalled carbon nanotubes and graphene oxide E Rozhina, S Batasheva, R Miftakhova, X Yan, A Vikulina, D Volodkin, ... Applied Clay Science 205, 106041, 2021 | 82 | 2021 |
Advancing CAR T-cell therapy for solid tumors: lessons learned from lymphoma treatment A Titov, A Valiullina, E Zmievskaya, E Zaikova, A Petukhov, R Miftakhova, ... Cancers 12 (1), 125, 2020 | 73 | 2020 |
Adoptive immunotherapy beyond CAR T-cells A Titov, E Zmievskaya, I Ganeeva, A Valiullina, A Petukhov, ... Cancers 13 (4), 743, 2021 | 69 | 2021 |
Metadherin: a therapeutic target in multiple cancers G Dhiman, N Srivastava, M Goyal, E Rakha, J Lothion-Roy, NP Mongan, ... Frontiers in oncology 9, 349, 2019 | 66 | 2019 |
Cyclin A1 and P450 aromatase promote metastatic homing and growth of stem-like prostate cancer cells in the bone marrow R Miftakhova, A Hedblom, J Semenas, B Robinson, A Simoulis, J Malm, ... Cancer research 76 (8), 2453-2464, 2016 | 54 | 2016 |
Flagella-mediated secretion of a novel Vibrio cholerae cytotoxin affecting both vertebrate and invertebrate hosts M Dongre, B Singh, KM Aung, P Larsson, R Miftakhova, K Persson, ... Communications Biology 1 (1), 59, 2018 | 48 | 2018 |
Targeted suppression of AR-V7 using PIP5K1α inhibitor overcomes enzalutamide resistance in prostate cancer cells M Sarwar, J Semenas, R Miftakhova, A Simoulis, B Robinson, ... Oncotarget 7 (39), 63065, 2016 | 48 | 2016 |
Isatin-Schiff base-copper (II) complex induces cell death in p53-positive tumors E Bulatov, R Sayarova, R Mingaleeva, R Miftakhova, M Gomzikova, ... Cell Death Discovery 4 (1), 103, 2018 | 41 | 2018 |
Therapeutic Editing of the TP53 Gene: Is CRISPR/Cas9 an Option? R Mirgayazova, R Khadiullina, V Chasov, R Mingaleeva, R Miftakhova, ... Genes 11 (6), 704, 2020 | 40 | 2020 |
Interfacial uploading of luminescent hexamolybdenum cluster units onto amino-decorated silica nanoparticles as new design of nanomaterial for cellular imaging and photodynamic … J Elistratova, A Mukhametshina, K Kholin, I Nizameev, M Mikhailov, ... Journal of colloid and interface science 538, 387-396, 2019 | 36 | 2019 |
Cytochalasin B-induced membrane vesicles convey angiogenic activity of parental cells MO Gomzikova, MN Zhuravleva, RR Miftakhova, SS Arkhipova, ... Oncotarget 8 (41), 70496, 2017 | 36 | 2017 |
CDK1 interacts with RARγ and plays an important role in treatment response of acute myeloid leukemia A Hedblom, K Laursen, R Miftakhova, M Sarwar, L Anagnostaki, ... Cell Cycle 12 (8), 1251-1266, 2013 | 34 | 2013 |
Knowns and unknowns about CAR-T cell dysfunction A Titov, Y Kaminskiy, I Ganeeva, E Zmievskaya, A Valiullina, ... Cancers 14 (4), 1078, 2022 | 33 | 2022 |
Breast cancer stem cell isolation X Jiao, AA Rizvanov, M Cristofanilli, RR Miftakhova, RG Pestell Breast Cancer: Methods and Protocols, 121-135, 2016 | 33 | 2016 |
A transient peak of infections during onset of rheumatoid arthritis: a 10-year prospective cohort study MI Arleevskaya, AG Gabdoulkhakova, YV Filina, RR Miftakhova, ... BMJ open 4 (8), e005254, 2014 | 31 | 2014 |
DNA methylation in ATRA-treated leukemia cell lines lacking a PML–RAR chromosome translocation R Miftakhova, T Sandberg, A Hedblom, T Nevzorova, JL Persson, ... Anticancer research 32 (11), 4715-4722, 2012 | 20 | 2012 |
Recent advances in the development of bioreactors for manufacturing of adoptive cell immunotherapies I Ganeeva, E Zmievskaya, A Valiullina, A Kudriaeva, R Miftakhova, ... Bioengineering 9 (12), 808, 2022 | 16 | 2022 |
Androgen dependent mechanisms of pro-angiogenic networks in placental and tumor development VM Metzler, S de Brot, RS Robinson, JN Jeyapalan, E Rakha, T Walton, ... Placenta 56, 79-85, 2017 | 15 | 2017 |
Base excision DNA repair deficient cells: From disease models to genotoxicity sensors DV Kim, AV Makarova, RR Miftakhova, DO Zharkov Current Pharmaceutical Design 25 (3), 298-312, 2019 | 11 | 2019 |